Dr. David James Hormozdi, MD

Dr. Hormozdi practices at BayCare St. Joseph's Hospital in Tampa, Florida, part of BayCare Health System.

Dr. Hormozdi's NPI, 1356577928, was assigned on June 9, 2009. Dr. Hormozdi graduated from WashU Medicine in 2009. Dr. Hormozdi holds Florida license ME127190.

Dr. Hormozdi's primary practice is BayCare St. Joseph's Hospital, at 3001 W Martin Luther King Jr Blvd, Tampa, FL 33607 in Hillsborough County. The practice phone is (813) 870-4398.

Dr. Hormozdi's primary practice is BayCare St. Joseph's Hospital in Tampa, Florida, part of BayCare Health System. The medical group on file is BayCare Medical Group. Dmand AI also links Dr. Hormozdi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hormozdi practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Hormozdi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Hormozdi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Hormozdi's licenses on file in 3 states: Florida, California and New York.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Hormozdi treats.

CMS data shows 984 Medicare services from Dr. Hormozdi across 16 procedure codes in 2024, for 409 Medicare patients. Medicare paid $83,874 for them.

CMS counts 409 Medicare patients who saw Dr. Hormozdi in 2024. The largest group is 65 to 74, with 216 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hormozdi's median patient age at 71, with 60% women.

In 2024, Dr. Hormozdi wrote 648 Medicare Part D claims for 325 patients. 76% of them were for generic drugs. CMS names the drug for 501 of them, across 11 drugs with 11 or more claims each, at $207,605 in total drug cost. In 2023, CMS named 428 claims across 10 drugs.

Dr. Hormozdi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hormozdi as offering telehealth. CMS counts 122 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Hormozdi, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Hormozdi. Dr. Hormozdi's most frequent co-authors are Kaharu Sumino, MD and Michael J. Walter, MD.

CMS Open Payments shows 140 general payments to Dr. Hormozdi from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Abbvie Inc. paid the most, $1,115.

Dr. Hormozdi graduated from WashU Medicine in 2009.

Dr. Hormozdi is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.